in a multicenter study 46 untreated patients with highly-malignant non-hodgkin 's lymphomas stage ii-iv received 6 courses of the following drug combination : cyclophosphamide 750 mg/m2 i.v . day 1 , adriamycin 50 mg/m2 i.v . day 1 , vincristine 2 mg i.v . day 1 , prednisolone 100 mg p.o . days 1-5 , and etoposide 100 mg/m2 i.v . days 3-5 .
C0024305
malignant non-hodgkin 's
C0042679
vincristine